A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Clinical trial NCT02891603 · COMPLETED
Trial details
- NCT number
- NCT02891603
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2022-01-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.